| Serial Number | 97908103 |
| Word Mark | IMMENSI-T |
| Filing Date | Wednesday, April 26, 2023 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, August 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 1, 2023 |
| Description of Mark | The mark consists of the wording "IMMENSI-T" in black stylized font appearing to the right of a stylized design consisting of a crossing line that transitions from pink to dark pink to dark orange to orange. The white appearing in the mark represents background and is not claimed as a feature of the mark. |
| Indication of Colors claimed | The color(s) pink, orange, and black are claimed as a feature of the mark. |
| Goods and Services | Providing health and medical information |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 24, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 24, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kite Pharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Santa Monica, CA 90404 |
| Party Name | Kite Pharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Santa Monica, CA 90404 |
| Event Date | Event Description |
| Monday, May 1, 2023 | NEW APPLICATION ENTERED |
| Thursday, June 8, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, July 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, May 24, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 25, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, June 14, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, June 14, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 14, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, June 14, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, June 26, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 1, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 7, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, August 1, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 26, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, February 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 7, 2024 | SOU EXTENSION 1 FILED |
| Friday, February 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 26, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 26, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 26, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, September 26, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, February 19, 2025 | SOU EXTENSION 3 FILED |
| Thursday, August 14, 2025 | SOU EXTENSION 4 FILED |
| Thursday, August 14, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 14, 2025 | SOU EXTENSION 4 GRANTED |
| Friday, August 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 19, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 19, 2025 | SOU EXTENSION 3 GRANTED |
| Thursday, February 20, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |